Cluster-randomized controlled trials: A tutorial

Marty Chaplin, Kerry Dwan
{"title":"Cluster-randomized controlled trials: A tutorial","authors":"Marty Chaplin,&nbsp;Kerry Dwan","doi":"10.1002/cesm.12024","DOIUrl":null,"url":null,"abstract":"<p>This tutorial focuses on cluster-randomized controlled trials (cluster-RCTs). We will explain what cluster-RCTs are, why they might be used, and how to include data from cluster-RCTs in systematic reviews.</p><p><b>What is a cluster-randomized controlled trial?</b></p><p>In most RCTs, individuals are randomly assigned to intervention groups. In a cluster-RCT, groups of individuals (e.g., schools, communities, or clinics) are randomized to intervention groups.</p><p><b>Why use a cluster-randomized controlled trial design?</b></p><p>Table 1 outlines reasons that a cluster-RCT design might be used by researchers, and provides an example for each of these reasons.</p><p><b>How do I perform risk of bias assessments for cluster-randomized controlled trials?</b></p><p>An adaptation of the Risk of Bias 2 tool [<span>1</span>] outlines issues that should be considered when assessing the risk of bias of cluster-RCTs. Detailed guidance on the use of the adapted tool is also available [<span>2</span>].</p><p><b>What is a “unit-of analysis” error?</b></p><p>Individuals from the same cluster are likely to respond in a similar way to each other, and therefore observations made for these individuals cannot be assumed to be independent. It is important that this dependency is accounted for when analyzing data from a cluster-RCT.</p><p>If the effects of clustering are ignored, and the analysis is conducted as if individuals were randomized, a “unit-of-analysis error” occurs [<span>3</span>], as the unit of analysis (the individual) is different to the unit of randomization (the cluster). When a “unit-of-analysis error” occurs, confidence intervals for the effect estimate will be artificially narrow and associated <i>p</i>-values will be artificially small. The trial will also have too much weight in any meta-analysis. Incorrect conclusions may therefore be drawn from the results of the cluster-RCT itself, and any meta-analyses that include the cluster-RCT.</p><p><b>How do I include data from a cluster-randomized controlled trial in a systematic review?</b></p><p>When a cluster-RCT is included in a systematic review (with or without a meta-analysis), it is important that the effect estimate and its corresponding confidence interval are adjusted for the clustered nature of the data.</p><p>The ideal approach is to extract cluster-adjusted effect estimates and a measure of uncertainty (i.e., confidence interval or standard error) that have been calculated by the trial authors using statistical methods such as multilevel models or generalized estimating equations. These effect estimates and the measure of uncertainty may be included in meta-analyses that use the generic inverse variance method.</p><p>Another acceptable approach is to conduct the analysis at the cluster level. The data set for analysis would include a summary measurement for each cluster, and the sample size is the number of clusters. These data can then be treated as if they were from an RCT that randomized individuals (individual-RCT); the standard formulae can be used to obtain effect estimates and confidence intervals, and if appropriate, the data can also be included in meta-analysis. A limitation of this approach is that sample size (and consequently, precision, and power) for the cluster-RCT may be greatly reduced.</p><p>This approach involves calculating the effective sample size for each arm of the trial. The effective sample size can be defined as the sample size that would be required for an individual-RCT to have the same power and precision as the cluster-RCT [<span>4</span>].</p><p>The ICC is a measure of the similarity of individuals within the same cluster with regard to a particular outcome [<span>5</span>], and is typically small. The ICC may be reported in the trial publication, or may be obtained from contact with trial authors. The design effect is usually the same for both arms of the trial.</p><p>For dichotomous outcomes, the number of individuals experiencing the event in each arm of the trial should also be divided by the same design effect. For continuous outcomes, means and standard deviations should remain unchanged.</p><p>If review authors have an effect estimate and standard error that are not adjusted for clustering, the standard error can be multiplied by the square root of the design effect (as defined above) to obtain a standard error that accounts for the clustering effect. Standard errors can be calculated from confidence intervals, and vice versa, as described in Chapter 6.3 of the Cochrane Handbook [<span>6</span>]. The effect estimate and adjusted standard error or confidence interval may then be included in meta-analyzes that use the generic inverse variance method.</p><p><b>Common queries</b></p><p><i>What if the ICC is not reported?</i></p><p>If the ICC is not available in the trial publication or from contact with trial authors, it may be possible to borrow an ICC from a similar trial. If the ICC is borrowed or estimated, sensitivity analyses can be undertaken to investigate the impact on analysis results of varying the ICC within plausible limits.</p><p><i>What if it is not possible to obtain a cluster-adjusted effect estimate?</i></p><p>If it is not possible to obtain cluster-adjusted effect estimates using any of these methods, and the review authors wish to present an unadjusted effect estimate in the text, tables, or meta-analyses, it is important to highlight that the confidence interval for the effect estimate is likely to be too narrow due to the lack of cluster-adjustment. If review authors do include unadjusted effect estimates from cluster-RCTs in meta-analyzes, sensitivity analyses should be performed to explore the impact of excluding these unadjusted effect estimates from the meta-analysis. It is also perfectly reasonable to exclude unadjusted effect estimates from meta-analyses completely.</p><p><i>Can I include cluster-RCTs and individual-RCTs in the same meta-analysis?</i></p><p>Theoretically, yes. It may be informative to perform stratified or subgroup analyses by unit of randomization (I.e. cluster or individual) to investigate whether the intervention effect varies between individual-RCTs and cluster-RCTs. For example, in a vaccine trial, the vaccine may be more effective if administered to all individuals within a village, rather than to only some individuals.</p><p><b>Further reading and online content</b></p><p>More information on cluster-RCTs, can be found in Chapter 23.1 of The Cochrane Handbook for Systematic Reviews of Interventions [<span>6</span>].</p><p>Cochrane Training have produced a micro-learning module on how to adjust data from cluster-RCTs to accompany this article [<span>7</span>] (Figure 1).</p><p>Professor Bland and Dr Kerry discuss cluster-randomized controlled trials in more detail in various papers published in the BMJ [<span>8-11</span>].</p><p><b>Marty Chaplin</b>: Conceptualization; writing—original draft; writing—review and editing. <b>Kerry Dwan</b>: Conceptualization; supervision; writing—review and editing.</p><p>The authors declare no conflict of interest.</p>","PeriodicalId":100286,"journal":{"name":"Cochrane Evidence Synthesis and Methods","volume":"1 7","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2023-09-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/cesm.12024","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cochrane Evidence Synthesis and Methods","FirstCategoryId":"1085","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/cesm.12024","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

This tutorial focuses on cluster-randomized controlled trials (cluster-RCTs). We will explain what cluster-RCTs are, why they might be used, and how to include data from cluster-RCTs in systematic reviews.

What is a cluster-randomized controlled trial?

In most RCTs, individuals are randomly assigned to intervention groups. In a cluster-RCT, groups of individuals (e.g., schools, communities, or clinics) are randomized to intervention groups.

Why use a cluster-randomized controlled trial design?

Table 1 outlines reasons that a cluster-RCT design might be used by researchers, and provides an example for each of these reasons.

How do I perform risk of bias assessments for cluster-randomized controlled trials?

An adaptation of the Risk of Bias 2 tool [1] outlines issues that should be considered when assessing the risk of bias of cluster-RCTs. Detailed guidance on the use of the adapted tool is also available [2].

What is a “unit-of analysis” error?

Individuals from the same cluster are likely to respond in a similar way to each other, and therefore observations made for these individuals cannot be assumed to be independent. It is important that this dependency is accounted for when analyzing data from a cluster-RCT.

If the effects of clustering are ignored, and the analysis is conducted as if individuals were randomized, a “unit-of-analysis error” occurs [3], as the unit of analysis (the individual) is different to the unit of randomization (the cluster). When a “unit-of-analysis error” occurs, confidence intervals for the effect estimate will be artificially narrow and associated p-values will be artificially small. The trial will also have too much weight in any meta-analysis. Incorrect conclusions may therefore be drawn from the results of the cluster-RCT itself, and any meta-analyses that include the cluster-RCT.

How do I include data from a cluster-randomized controlled trial in a systematic review?

When a cluster-RCT is included in a systematic review (with or without a meta-analysis), it is important that the effect estimate and its corresponding confidence interval are adjusted for the clustered nature of the data.

The ideal approach is to extract cluster-adjusted effect estimates and a measure of uncertainty (i.e., confidence interval or standard error) that have been calculated by the trial authors using statistical methods such as multilevel models or generalized estimating equations. These effect estimates and the measure of uncertainty may be included in meta-analyses that use the generic inverse variance method.

Another acceptable approach is to conduct the analysis at the cluster level. The data set for analysis would include a summary measurement for each cluster, and the sample size is the number of clusters. These data can then be treated as if they were from an RCT that randomized individuals (individual-RCT); the standard formulae can be used to obtain effect estimates and confidence intervals, and if appropriate, the data can also be included in meta-analysis. A limitation of this approach is that sample size (and consequently, precision, and power) for the cluster-RCT may be greatly reduced.

This approach involves calculating the effective sample size for each arm of the trial. The effective sample size can be defined as the sample size that would be required for an individual-RCT to have the same power and precision as the cluster-RCT [4].

The ICC is a measure of the similarity of individuals within the same cluster with regard to a particular outcome [5], and is typically small. The ICC may be reported in the trial publication, or may be obtained from contact with trial authors. The design effect is usually the same for both arms of the trial.

For dichotomous outcomes, the number of individuals experiencing the event in each arm of the trial should also be divided by the same design effect. For continuous outcomes, means and standard deviations should remain unchanged.

If review authors have an effect estimate and standard error that are not adjusted for clustering, the standard error can be multiplied by the square root of the design effect (as defined above) to obtain a standard error that accounts for the clustering effect. Standard errors can be calculated from confidence intervals, and vice versa, as described in Chapter 6.3 of the Cochrane Handbook [6]. The effect estimate and adjusted standard error or confidence interval may then be included in meta-analyzes that use the generic inverse variance method.

Common queries

What if the ICC is not reported?

If the ICC is not available in the trial publication or from contact with trial authors, it may be possible to borrow an ICC from a similar trial. If the ICC is borrowed or estimated, sensitivity analyses can be undertaken to investigate the impact on analysis results of varying the ICC within plausible limits.

What if it is not possible to obtain a cluster-adjusted effect estimate?

If it is not possible to obtain cluster-adjusted effect estimates using any of these methods, and the review authors wish to present an unadjusted effect estimate in the text, tables, or meta-analyses, it is important to highlight that the confidence interval for the effect estimate is likely to be too narrow due to the lack of cluster-adjustment. If review authors do include unadjusted effect estimates from cluster-RCTs in meta-analyzes, sensitivity analyses should be performed to explore the impact of excluding these unadjusted effect estimates from the meta-analysis. It is also perfectly reasonable to exclude unadjusted effect estimates from meta-analyses completely.

Can I include cluster-RCTs and individual-RCTs in the same meta-analysis?

Theoretically, yes. It may be informative to perform stratified or subgroup analyses by unit of randomization (I.e. cluster or individual) to investigate whether the intervention effect varies between individual-RCTs and cluster-RCTs. For example, in a vaccine trial, the vaccine may be more effective if administered to all individuals within a village, rather than to only some individuals.

Further reading and online content

More information on cluster-RCTs, can be found in Chapter 23.1 of The Cochrane Handbook for Systematic Reviews of Interventions [6].

Cochrane Training have produced a micro-learning module on how to adjust data from cluster-RCTs to accompany this article [7] (Figure 1).

Professor Bland and Dr Kerry discuss cluster-randomized controlled trials in more detail in various papers published in the BMJ [8-11].

Marty Chaplin: Conceptualization; writing—original draft; writing—review and editing. Kerry Dwan: Conceptualization; supervision; writing—review and editing.

The authors declare no conflict of interest.

Abstract Image

集群随机对照试验:教程
本教程的重点是集群随机对照试验(集群随机对照实验)。我们将解释什么是集群随机对照试验,为什么可能使用它们,以及如何在系统综述中包括集群随机对照研究的数据。什么是整群随机对照试验?在大多数随机对照试验中,个体被随机分配到干预组。在集群随机对照试验中,将个体组(如学校、社区或诊所)随机分为干预组。为什么要使用整群随机对照试验设计?表1概述了研究人员可能使用集群随机对照试验设计的原因,并为每一个原因提供了一个例子。我如何对集群随机对照试验进行偏倚风险评估?对偏倚风险2工具[1]的改编概述了评估集群随机对照试验偏倚风险时应考虑的问题。还提供了关于使用自适应工具的详细指南[2]。什么是“分析单位”错误?来自同一集群的个体可能会以相似的方式做出反应,因此不能假设对这些个体的观察是独立的。重要的是,在分析聚类-RCT的数据时要考虑到这种依赖性。如果忽略聚类的影响,并且分析是像对个体进行随机化一样进行的,则会出现“分析误差单位”[3],因为分析单位(个体)与随机化单位(聚类)不同。当出现“分析误差单位”时,效应估计的置信区间将被人为地缩小,相关的p值将被人为缩小。该试验在任何荟萃分析中也会有太大的分量。因此,从整群随机对照试验本身的结果以及包括整群-RCT在内的任何荟萃分析中都可能得出错误的结论。我如何在系统综述中纳入整群随机控制试验的数据?当聚类随机对照试验被纳入系统综述(有或没有荟萃分析)时,重要的是要根据数据的聚类性质调整效应估计及其相应的置信区间。理想的方法是提取聚类调整后的效应估计和不确定性度量(即置信区间或标准误差),这些不确定性度量是试验作者使用统计方法(如多级模型或广义估计方程)计算的。这些影响估计和不确定性度量可以包括在使用通用逆方差方法的荟萃分析中。另一种可以接受的方法是在集群一级进行分析。用于分析的数据集将包括每个聚类的汇总测量,样本量是聚类的数量。然后可以将这些数据视为来自随机对照试验的数据,该随机对照试验对个体进行随机化(个体随机对照试验);标准公式可用于获得效应估计和置信区间,如果合适,数据也可纳入荟萃分析。这种方法的局限性在于,聚类RCT的样本大小(以及因此的精度和功率)可能会大大降低。这种方法包括计算试验中每一组的有效样本量。有效样本量可以定义为单个随机对照试验具有与聚类随机对照试验相同的能力和精度所需的样本量[4]。ICC是衡量同一聚类内个体在特定结果方面相似性的指标[5],通常很小。ICC可以在审判出版物中报告,也可以通过与审判作者的联系获得。试验的两个阶段的设计效果通常是相同的。对于二分结果,在试验的每一组中经历该事件的个体数量也应除以相同的设计效果。对于连续结果,均值和标准差应保持不变。如果评审作者的效应估计和标准误差没有针对聚类进行调整,则可以将标准误差乘以设计效应的平方根(如上所述),以获得解释聚类效应的标准误差。标准误差可以根据置信区间计算,反之亦然,如Cochrane手册[6]第6.3章所述。然后,可以将效应估计和调整后的标准误差或置信区间包括在使用通用逆方差方法的元分析中。常见问题如果没有报告国际刑事法院怎么办?如果审判出版物或与审判作者的联系中没有国际刑事法院,则可以从类似的审判中借用国际刑事法院。如果借用或估计了ICC,则可以进行敏感性分析,以调查在合理限度内改变ICC对分析结果的影响。 如果无法获得集群调整后的效果估计,该怎么办?如果使用这些方法中的任何一种都无法获得经聚类调整的效果估计,并且综述作者希望在文本、表格或荟萃分析中提供未经调整的效果评估,则需要强调的是,由于缺乏聚类调整,效果估计的置信区间可能太窄。如果综述作者在荟萃分析中确实包括了来自聚类随机对照试验的未调整效果估计,则应进行敏感性分析,以探讨将这些未调整效果评估从荟萃分析中排除的影响。将未经调整的影响估计完全排除在荟萃分析之外也是完全合理的。我可以在同一荟萃分析中包括集群随机对照试验和个体随机对照试验吗?理论上是的。按随机化单位(即集群或个体)进行分层或亚组分析,以调查个体随机对照试验和集群随机对照试验之间的干预效果是否不同,这可能会提供信息。例如,在疫苗试验中,如果给一个村庄内的所有人接种疫苗,而不是只给一些人接种,疫苗可能会更有效。进一步阅读和在线内容关于集群随机对照试验的更多信息,可以在《Cochrane干预措施系统评价手册》[6]的第23.1章中找到。Cochrane Training制作了一个关于如何调整集群随机对照试验数据的微观学习模块,以配合本文[7](图1)。Bland教授和Kerry博士在《英国医学杂志》[8-11]上发表的多篇论文中更详细地讨论了集群随机对照实验。Marty Chaplin:概念化;书写——原始草稿;写作——复习和编辑。Kerry Dwan:概念化;监督;写作——复习和编辑。提交人声明没有利益冲突。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信